Shanghai Shenqi Pharmaceutical Investment Management Past Earnings Performance
Past criteria checks 2/6
Shanghai Shenqi Pharmaceutical Investment Management has been growing earnings at an average annual rate of 50.6%, while the Pharmaceuticals industry saw earnings growing at 2.7% annually. Revenues have been declining at an average rate of 3.1% per year. Shanghai Shenqi Pharmaceutical Investment Management's return on equity is 1.5%, and it has net margins of 1.9%.
How Shanghai Shenqi Pharmaceutical Investment Management makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
SHSE:600613 Revenue, expenses and earnings (CNY Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
1,895
36
704
30
31 Dec 25
1,952
38
738
30
30 Sep 25
1,883
62
701
23
30 Jun 25
1,899
66
730
22
31 Mar 25
1,954
62
756
32
31 Dec 24
2,049
71
801
33
30 Sep 24
2,194
50
860
33
30 Jun 24
2,246
60
869
36
31 Mar 24
2,333
57
950
22
31 Dec 23
2,341
57
967
32
30 Sep 23
2,386
59
1,047
41
30 Jun 23
2,392
51
1,082
49
31 Mar 23
2,383
49
1,076
59
31 Dec 22
2,389
49
1,102
46
30 Sep 22
2,313
72
1,097
59
30 Jun 22
2,350
57
1,198
52
31 Mar 22
2,338
71
1,222
47
31 Dec 21
2,303
70
1,216
51
30 Sep 21
2,193
-141
1,359
44
30 Jun 21
2,135
-325
1,306
46
31 Mar 21
2,029
-328
1,247
50
31 Dec 20
1,819
-341
1,119
43
30 Sep 20
1,836
-145
986
28
30 Jun 20
1,856
55
951
22
31 Mar 20
1,844
69
949
21
31 Dec 19
1,928
84
1,010
20
30 Sep 19
1,980
124
1,036
27
30 Jun 19
1,907
105
1,003
28
31 Mar 19
1,934
100
999
23
31 Dec 18
1,853
106
948
23
30 Sep 18
1,883
114
918
27
30 Jun 18
1,894
137
916
31
31 Mar 18
1,772
138
870
25
31 Dec 17
1,736
130
849
24
30 Sep 17
1,762
165
861
13
30 Jun 17
1,650
164
827
0
31 Mar 17
1,657
166
848
0
31 Dec 16
1,598
182
832
0
30 Sep 16
1,592
168
845
0
30 Jun 16
1,604
192
854
0
31 Mar 16
1,553
207
842
0
31 Dec 15
1,593
217
895
0
30 Sep 15
1,400
192
828
0
30 Jun 15
1,381
187
826
0
Quality Earnings: 600613 has high quality earnings.
Growing Profit Margin: 600613's current net profit margins (1.9%) are lower than last year (3.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 600613 has become profitable over the past 5 years, growing earnings by 50.6% per year.
Accelerating Growth: 600613's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 600613 had negative earnings growth (-42.1%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-1.6%).
Return on Equity
High ROE: 600613's Return on Equity (1.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/23 05:41
End of Day Share Price
2026/06/23 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.